T1	Participants 139 232	patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).
T2	Participants 242 281	Radiation Therapy Oncology Group (RTOG)
T3	Participants 715 760	252 of the 331 patients were evaluable by GPA
T4	Participants 772 791	211 had lung cancer
T5	Participants 793 829	Breast cancer patients were excluded
T6	Participants 962 979	treatment groups,
T7	Participants 1708 1728	ung cancer patients,
T8	Participants 1862 1884	patients with high GPA
T9	Participants 2079 2148	patients with multiple BM and high GPA when treated with WBRT and SRS
